Our library of drug research abstracts drawn from the medical literature is updated on a regular schedule, and you can be assured that new triderm research articles will be listed here shortly after becoming available to us.
Related Sponsors
Medical research on triderm
[Our experience using triderm for the treatment of external otitis]
Vestn Otorinolaringol. 2004; 42-3
Vakhrushev SG, Pronina IuV, Zyrianov MM, Bugakova TM
Minerva Pediatr. 2002 Oct; 54(5): 465-74
Nemelka O, Bleidel D, Fabrizi G, Camplone G, Occella C, Marzatico F, Pecis L, Bocchietto E
In this paper we present the preliminary results of a multi-center clinical investigation carried out on a new topical product (Triderm(R) Lenil+) containing Superoxidodismutase (SOD), 18-beta glycyrrethic acid, Vitamin E, alpha bisabolol and a new patented antioxidant molecule, Furfuryl palmitate. These active agents altogether protect skin from cell damages that promote the inflammatory syndrome; their action is furthermore sustained by agents such as phytosphingosine and phytosterols that act to repair the skin barrier. Furfuryl palmitate is an ester with a strong quenching ability towards the singlet oxygene (1O2) and with a high permeability potential through the biological membranes, thanks to its lipophylic formula. Further than being among the main responsible for skin ageing, the 1O2 is involved in the genesis of many topical pathologies such as allergic and irritant dermatitis, atopic dermatitis, inflammation, psoriasis and sunburns. The product has been extensively tested for its effectiveness and skin tolerability on a selected population of 60 children and babies with age ranging from 2 months to 14 years, suffering mainly with atopic dermatitis and irritant dermatitis. The topical use of the product caused a significant improvement of the inflammatory skin conditions, with evident and fast inflammation and eczema reduction in all the investigated pathologies, as shown in the present study. The product has been formulated in order to avoid any sensitisation risk and did not show any relevant side effect. It is particularly suitable in the treatment of pediatric dermatitis with symptoms like eczema, itching, desquamation and xerosis.
[A trial of the use of Triderm preparations]
Voen Med Zh. 2000 May; 321(5): 40-1
Komaristov IA
[Triderm in the treatment of atopic dermatitis]
Voen Med Zh. 1999 Feb; 320(2): 53-5
Kaliuzhnaia DD